<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01247142</url>
  </required_header>
  <id_info>
    <org_study_id>S52756</org_study_id>
    <nct_id>NCT01247142</nct_id>
  </id_info>
  <brief_title>Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the diagnostic potential of biomarkers for invasive&#xD;
      pulmonary aspergillosis in exhaled breath condensate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Invasive pulmonary aspergillosis (IPA) is a life-threatening infection in immunocompromised&#xD;
      patients. The poor prognosis of the disease is partly attributed to difficulties encountered&#xD;
      with the diagnosis of this infection. Invasive sampling procedures are often precluded in&#xD;
      these patients. In addition, conventional diagnostic techniques lack sensitivity. Recently&#xD;
      there has been increasing interest in the investigation of the lungs by noninvasive means&#xD;
      including measurement of biomarkers in exhaled breath (e.g. NO) and those found in the cooled&#xD;
      and condensed exhalate,termed EBC. It has been demonstrated that a measurable fraction of the&#xD;
      EBC in healthy subjects is derived from aerosolized airway lining fluid. The presence of&#xD;
      biomarkers for IPA will be investigated in EBC of patients with IPA, compared to controls.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The identification of biomarkers for invasive pulmonary aspergillosis (IPA) in exhaled breath condensate (EBC)</measure>
    <time_frame>15 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Invasive Pulmonary Aspergillosis</condition>
  <arm_group>
    <arm_group_label>Invasive pulmonary aspergillosis (IPA)</arm_group_label>
    <description>Patients with proven or probable invasive pulmonary aspergillosis (IPA) (EORTC/MSG criteria) or putative IPA (Blot et al. Am J Respir Crit Care Med 2012)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Patients without signs of infection.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      exhaled breath condensate&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized adult patients of the department of Hematology or Intensive Care Unit,&#xD;
        University Hospital, Leuven, Belgium&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hospitalisation in the hematology or intensive care department&#xD;
&#xD;
          -  age &gt; 16 years&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
          -  proven or probable IPA (EORTC/ MSG criteria)&#xD;
&#xD;
          -  galactomannan positivity in BAL or serum&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt; 16 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>November 23, 2010</study_first_submitted>
  <study_first_submitted_qc>November 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2010</study_first_posted>
  <last_update_submitted>July 4, 2014</last_update_submitted>
  <last_update_submitted_qc>July 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Edith Vermeulen</investigator_full_name>
    <investigator_title>PhD fellow</investigator_title>
  </responsible_party>
  <keyword>invasive pulmonary aspergillosis</keyword>
  <keyword>exhaled breath condensate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspergillosis</mesh_term>
    <mesh_term>Pulmonary Aspergillosis</mesh_term>
    <mesh_term>Invasive Pulmonary Aspergillosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

